Skip to main content
. 2019 Mar 26;2019(3):CD004705. doi: 10.1002/14651858.CD004705.pub5

NCT02991781.

Trial name or title Combined bio‐ and neuro‐ feedback vs. varenicline use for smoking cessation
Methods Randomised, parallel‐group, open‐label trial
Participants 140 participants:
Inclusion criteria:
  • Being continuous tobacco smokers (> 10 cigarettes per day) for at least 6 months

  • Being unemployed for at least 3 months

  • Being diagnosed with asthma

  • Being diagnosed with COPD

  • Age < 35, for the group of young unemployed

  • Age > 35 years, for the groups of asthma and COPD patients


Exclusion criteria:
  • Diagnosed neurological, mental, or psychiatric illness

  • Drug‐resistant epilepsy

Interventions This study will develop and experimentally test the efficiency of a neurofeedback (NF) training protocol for smoking cessation. As non‐pharmacological, non‐invasive, and painless brainwave technique, NF contributes to teach individuals how they can take control of their mind through operant conditioning. NF regulates brain function in a natural way. The protocol will consist of 5 sessions of skin temperature biofeedback and 20 sessions of a neurofeedback training protocol that will consist of Alpha‐Theta ratio up‐training. The aim of the training is to reach a cross‐over state, were initially Alpha activity will increase and then in a deeper state, the Theta activity will take over. This state is associated with a reverie and disidentification with problems, stress, or traumatic experiences. Participants will therefore will learn how to increase their Theta/Alpha ratio.
The neurofeedback intervention will be compared with a different group of participants receiving an intervention based on varenicline use for approximately 3 months. The electrophysiological evaluation of the efficacy of the intervention will include EEG resting state and a sleep polysomnography measurement. Questionnaires and clinical evaluation include the same measurements as the neurofeedback intervention but only at 3 time points: prior, during, after the completion of the study.
Outcomes Standardised percentage of participants that give up smoking (Time Frame 2 years)
Starting date January 2017
Contact information Professor Panos Bamidis
bamidis@auth.gr
Notes Not sure if it will be possible to isolate the effect of biofeedback